Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 3—March 2011

Research

Epidemiology of Mycobacterium bovis Disease in Humans, the Netherlands, 1993–2007

Christof J. MajoorComments to Author , Cecile Magis-Escurra, Jakko van Ingen, Martin J. Boeree, and Dick van Soolingen
Author affiliations: Author affiliations: Academic Medical Center, Amsterdam, the Netherlands (C.J. Majoor); Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (C. Magis-Escurra, J. van Ingen, M.J. Boeree, D. van Soolingen); National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands (J. van Ingen, D. van Soolingen)

Main Article

Table 1

Clinical and demographic data for Mycobacterium bovis TB case-patients, by sex, as recorded in the Netherlands Tuberculosis Registry, the Netherlands, 1993–2007*

Characteristic Dutch,
no. (%),
n = 138 Foreign-born, no. (%),†
n = 93 Total,
no. (%),
N = 231
All case-patients
M 56 (40.6) 49 (52.7) 105 (45.5)
F
82 (59.4)
44 (47.3)
126 (54.5)
Age, y
0–60 115 (49.7)
M 13 45
F 22 35
>60 116 (50.3)
M 43 4
F
60
9

Localization
Pulmonary 80 (34.6)
M 26 25
F 22‡
Respiratory tract 19 (8.2)
M 5 5
F 8 1
Meningeal and CNS 6 (2.5)
M 2 0
F F 0
Intestinal tract 13 (5.6)
M 0 3
F 5 5
Bone and joint 12 (5.2)
M 4 2
F 5 1
Urogenital tract 13 (5.6)
M 4 3
F 4 2
Other organs (e.g., lymph nodes) 59 (25.5)
M 5 9
F 24¶ 21#
Miliary TB 11 (4.8)
M 6 0
F 3 2
Unknown 18 (7.8)
M 4 2
F 7 5

*TB, tuberculosis; CNS, central nervous system.
†Foreign-born patients originated from other European countries (n = 6), Africa (n = 69), Asia (n = 9), South America (n = 3), and unknown areas (n = 6).
‡p = 0.018.
§p<0.001.
¶p = 0.004.
#p = 0.002.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO